Even if the technique proves troublesome, it represents a fresh approach to a question that currently looks important: what bloodstream biomarkers can we measure to diagnose and monitor chronic diseases such as Alzheimer???s and cancer? 18 months ago, peptoids looked like they might be a really cool strategy for exploring that topic.